share_log

Krystal Biotech(KRYS.US) Director Sells US$3.28 Million in Common Stock

moomoo News ·  May 22 18:58

$Krystal Biotech (KRYS.US)$ Director Gangolli Julian S sold 20,000 shares of common stock on May 20, 2024 at an average price of $164.1345 for a total value of $3.28 million.

1716418689795267556.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment